Cg Oncology logo

Cg Oncology Share Price (NASDAQ: CGON)

$26.85

0.14

(0.52%)

Last updated on

Check the interactive Cg Oncology Stock chart to analyse performance

Cg Oncology stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$26.25
    Today's High:$26.85

    Day's Volatility :2.23%

  • 52 Weeks Low:$14.80
    52 Weeks High:$40.47

    52 Weeks Volatility :63.43%

Cg Oncology Stock Returns

PeriodCg Oncology Inc.Index (Russel 2000)
3 Months
0.98%
0.0%
6 Months
6.97%
0.0%
1 Year
-24.09%
0.0%
3 Years
-27.76%
-4.7%

Cg Oncology Inc. Key Stats

Check Cg Oncology key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$26.71
Open
$26.69
Today's High
$26.85
Today's Low
$26.25
Market Capitalization
$2.0B
Today's Volume
$400.0K
52 Week High
$40.47
52 Week Low
$14.8
Revenue TTM
$551.0K
EBITDA
$-157.1M
Earnings Per Share (EPS)
$-1.78
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-16.58%

Stock Returns calculator for Cg Oncology Stock including INR - Dollar returns

The Cg Oncology stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Cg Oncology investment value today

Current value as on today

₹81,196

Returns

₹18,804

(-18.8%)

Returns from Cg Oncology Stock

₹24,088 (-24.09%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Cg Oncology Stock

19%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Cg Oncology Stock from India on INDmoney has increased by 19% in the last 30 days, reflecting an upward trend in search activity.

Analyst Recommendation on Cg Oncology Stock

Rating
Trend

Buy

    81%Buy

    18%Hold

    0%Sell

Based on 11 Wall street analysts offering stock ratings for Cg Oncology(by analysts ranked 0 to 5 stars)

Cg Oncology Share Price Target

What analysts predicted

Upside of 123.09%

Target:

$59.90

Current:

$26.85

Cg Oncology share price target is $59.90, a slight Upside of 123.09% compared to current price of $26.85 as per analysts' prediction.

Cg Oncology Stock Insights

  • Price Movement

    In the last 1 year, CGON stock has moved down by -27.2%
  • CGON vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 97.1%
  • Price to Sales

    ForCGON every $1 of sales, investors are willing to pay $3356.3, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.5 for every $1 of sales.

Cg Oncology Technicals Summary

Sell

Neutral

Buy

Cg Oncology is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Cg Oncology Inc. Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Cg Oncology Inc. logo
2.05%
6.97%
-24.09%
-27.76%
-27.76%
Regeneron Pharmaceuticals, Inc. logo
6.48%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
1.77%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-14.45%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
13.79%
83.28%
75.87%
111.28%
242.25%

Cg Oncology Dividend announcements

  • Cg Oncology Earnings

    Cg Oncology’s price-to-earnings ratio stands at None

About Cg Oncology Inc.

CG Oncology, Inc., a late-stage clinical biopharmaceutical company, develops and commercializes backbone bladder-sparing therapeutics for patients with bladder cancer. The company develops BOND-003, which is in phase 3 clinical trial for the treatment of high-risk bacillus calmette guerin (BCG)-unresponsive non-muscle invasive bladder cancer (NMIBC) patients; CORE-001 that is in phase 2 clinical trial to treat cretostimogene in combination with pembrolizumab in high-risk BCG-unresponsive NMIBC patients; and CORE-002 for the treatment of cretostimogene in combination with the checkpoint inhibitor nivolumab in muscle invasive bladder cancer patients. It also develops PIVOT-006, a cretostimogene monotherapy that is in phase 3 clinical trial for intermediate-risk NMIBC following transurethral resection of the bladder tumor; and CORE-008, which is in phase 2 clinical trial for treating patients with high-risk NMIBC, including BCG-exposed and BCG-naïve NMIBC patients. The company was formerly known as Cold Genesys, Inc. and changed its name to CG Oncology, Inc. in June 2020. CG Oncology, Inc. was founded in 2010 and is headquartered in Irvine, California.
Organization
Cg Oncology
Employees
113
CEO
Mr. Arthur Kuan
Industry
Miscellaneous

Key Management of Cg Oncology Inc.

NameTitle
Mr. Arthur Kuan
Chairman & CEO
Mr. Ambaw Bellete M.S.
President & COO
Mr. Robert Lapetina
Interim Principal Financial & Accounting Officer
Mr. Swapnil Bhargava Ph.D.
Chief Technical Officer
Ms. Amy Steele
Vice President of Finance & Administration
Mr. Joshua F. Patterson
General Counsel, Chief Compliance Officer & Secretary
Ms. Sarah Connors
Vice President of Communications & Patient Advocacy
Mr. Bing Kung
Vice President of Corporate Development
Dr. Vijay Kasturi M.D.
Chief Medical Officer

Important FAQs about investing in CGON Stock from India :

What is Cg Oncology share price today?

Cg Oncology share price today is $26.85 as on at the close of the market. Cg Oncology share today touched a day high of $26.85 and a low of $26.25.

What is the 52 week high and 52 week low for Cg Oncology share?

Cg Oncology share touched a 52 week high of $40.47 and a 52 week low of $14.80. Cg Oncology stock price today i.e. is closed at $26.85, lower by 33.65% versus the 52 week high.

How to invest in Cg Oncology Stock (CGON) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Cg Oncology on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Cg Oncology Shares that will get you 0.0559 shares as per Cg Oncology share price of $26.85 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Cg Oncology Stock (CGON) from India?

Indian investors can start investing in Cg Oncology (CGON) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Cg Oncology stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Cg Oncology share’s latest price of $26.85 as on August 30, 2025 at 1:29 am IST, you will get 0.3724 shares of Cg Oncology. Learn more about fractional shares .

What are the returns that Cg Oncology has given to Indian investors in the last 5 years?

Cg Oncology stock has given -27.76% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?